Condition: Heart Failure · Sponsor: Baker Heart and Diabetes Institute
This is a prospective study in which a process of identifying and improving a reduction of functional capacity in COVID-19 survivors \>50 years old. The overall goal of this study to identify the feasibility and value of risk-guided medical therapy and exercise intervention in COVID-19 survivors.
This description comes directly from the study's public registry record.
Joel Smith, MSc · +61385321964 · joel.smith@baker.edu.au
Thomas H Marwick, MD,PhD,MPH · +61385321550 · tom.marwick@baker.edu.au
Always discuss trial participation with your own doctor first.
| Baker Heart and Diabetes Institute | Melbourne, Victoria, Australia | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04983823